文献速递妇科

微创手术率作为子宫内膜癌的质量指标

Minimally Invasive Surgery Rate as a Quality Metric for Endometrial Cancer.
PubMed 文献 · J Minim Invasive Gynecol · 2019-10-23

该回顾性队列研究纳入2015年美国国家癌症数据库中每年诊治至少20例子宫内膜癌患者的510家医院、共20670例行子宫切除术的上皮性、Charlson合并症评分为0、I至III期子宫内膜癌女性,比较微创子宫切除术占比≥80%的医院与未达该指标的医院的诊疗模式与结局。283家(55%)医院达到该指标(总体微创率89%),未达标的227家医院微创率为61%;达到指标的医院患者更多为白人、私人保险、I期及子宫内膜样组织学,机器人手术更多、中转开腹更少,淋巴结评估和当日或次日出院更多、非计划30天再入院更少。作者认为,子宫内膜癌微创率≥80%在全国范围内可行,并与其他医院层面的高质量医疗指标相关。

要点

  • 达到微创率≥80%指标的医院共283家(55%),其总体微创率为89%。
  • 未达标医院227家,子宫内膜癌子宫切除术中61%采用微创方式。
  • 高微创医院中转开腹更少(1.5% vs 3.2%,aOR 0.47,95%CI 0.39-0.57)。

核心结论

  • 子宫内膜癌微创手术率≥80%作为质量指标在全国范围内可行,并与其他医院层面的高质量医疗指标相关。

研究设计与样本

  • 回顾性队列研究;纳入2015年美国国家癌症数据库中每年诊治至少20例子宫内膜癌患者的医院,共510家医院、20670例女性。
  • 研究对象为因子宫内膜癌行子宫切除术、上皮性组织学、Charlson合并症评分为0、I至III期的女性。
  • 比较微创子宫切除术占比≥80%的医院与未达该指标的医院之间患者特征、诊疗模式和结局。

主要发现

  • 510家医院共治疗20670例子宫内膜癌女性;283家(55%)医院微创率≥80%(高微创医院,总体微创率89%),未达标的227家医院微创率为61%。
  • 高微创医院患者更多为白人(87% vs 82%,p<.001)、私人保险(53% vs 49%,p<.001)、I期(84% vs 82%,p=.002)及子宫内膜样组织学(79% vs 76%,p<.001)。
  • 高微创医院机器人手术更多(80% vs 71%),中转开腹更少(1.5% vs 3.2%,aOR 0.47,95%CI 0.39-0.57)(均p<.001)。
  • 高微创医院术中淋巴结评估更多(76% vs 69%;aOR 1.43,95%CI 1.35-1.53),当日或次日出院更多(74% vs 57%;aOR 2.27,95%CI 2.13-2.42)。
  • 高微创医院非计划30天再入院更少(1.8% vs 2.9%;aOR 0.64,95%CI 0.53-0.77)。

关键数值与推荐

  • 微创手术率质量指标阈值为≥80%的子宫切除术以微创方式完成。
  • 高微创医院总体微创率为89%,未达标医院为61%。

临床怎么用

  • 作者认为,子宫内膜癌微创率≥80%在全国范围内可行,并与其他医院层面的高质量医疗指标相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To determine the frequency with which Commission on Cancer-accredited hospitals met a metric of ≥80% minimally invasively performed hysterectomies for endometrial cancer and to compare the clinical outcomes of hospitals meeting this metric with those that did not. DESIGN: Retrospective cohort study. SETTING: Hospitals caring for ≥20 endometrial cancer patients per year recorded in the National Cancer Database in 2015 were included. PATIENTS: Women who had undergone hysterectomy for endometrial cancer and had an epithelial histology, a Charlson comorbidity score of 0, and stage I to III disease. INTERVENTION: Patient characteristics, patterns of care, and outcomes were compared between hospitals performing ≥80% minimally invasive hysterectomies and hospitals not meeting this metric. MEASUREMENTS AND MAIN RESULTS: The hospitals (n = 510) treated 20 670 women with endometrial cancer. In 283 (55%) hospitals ≥80% of hysterectomies were minimally invasively performed (high-minimally invasive surgery [MIS] hospitals, overall MIS rate 89%). In the 227 hospitals that did not meet this metric, 61% of hysterectomies for endometrial cancer were performed using a minimally invasive approach. In high-MIS hospitals, patients were more likely to be white (87% vs 82%, p<.001), privately insured (53% vs 49%, p <.001), and have stage I disease (84% vs 82%, p = .002) and an endometrioid histology (79% vs 76%, p <.001). Surgery was more often performed robotically (80% vs 71%), and conversion to laparotomy was less likely (1.5% vs 3.2%, adjusted odds ratio [aOR], 0.47; 95% confidence interval [CI], 0.39-0.57) (both p <.001). Patients treated at high-MIS hospitals were more likely to have undergone lymph node assessment at the time of surgery (76% vs 69%; aOR, 1.43; 95% CI, 1.35-1.53) and been discharged on the same or next day (74% vs 57%; aOR, 2.27; 95% CI, 2.13-2.42) and were less likely to have an unplanned 30-day readmission (1.8% vs 2.9%; aOR, 0.64; 95% CI, 0.53-0.77). CONCLUSION: An MIS rate of ≥80% for endometrial cancer is feasible on a national scale and is associated with other hospital-level measurements of high-quality care.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Polan RM, Tanner EJ, Barber EL, et al. Minimally Invasive Surgery Rate as a Quality Metric for Endometrial Cancer. J Minim Invasive Gynecol. 2019. PMID: 31655129. doi:10.1016/j.jmig.2019.10.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。